Ambagon Therapeutics
Expanding the druggable proteome to drug intrinsically disordered proteins.
14 employees · est. 2020 · Eindhoven, The Netherlands
Ambagon Therapeutics is the older company (2021 vs 2020).
Side-by-Side Comparison
| Metric | AI Proteins | Ambagon Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2020 older |
| Headquarters | ||
| Headquarters | Boston, United States | Eindhoven, The Netherlands |
| Employees | ||
| Employees | 39 | 14 |
| Industry | ||
| Industry | AI, Biotechnology, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series A | Series Unknown |
| Total Funding | ||
| Total Funding | $86.00M | $148.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 3 |
| Services | ||
| Services | Protein Design, Biological Engineering, Drug Discovery | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Researchers, Healthcare Providers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | AI-enabled Design, De Novo Protein Therapeutics, Miniproteins, Drug Discovery Platform, Synthetic Protein Engineering, High-throughput Discovery, IND-enabling Studies, Biopharmaceutical Partnerships, Protein Design, Protein Engineering, Machine Learning In Biotech, Laboratory Automation, Therapeutic Applications, Biologics Development | Biotech, Cancer Research, Oncology, Small Molecule Drugs, Protein Stabilization, Therapeutics, Drug Discovery, Clinical Needs, Unmet Needs, Tumor-suppressing Protein, Founders, Intrinsically Disordered Proteins, 14-3-3 Adaptor Proteins, Startup, Investment |
| Website | ||
| Website | aiproteins.com | ambagontx.com |
About AI Proteins
AI Proteins, based in Boston, is a forward-thinking biotech startup founded in 2021. Focused on revolutionizing protein therapeutics, the company employs a fusion of AI-enabled design with a high-throughput drug discovery platform to create novel miniproteins for diverse therapeutic applications. Th...
About Ambagon Therapeutics
Ambagon Therapeutics is a biotechnology startup founded in 2020, based in the United States. The company's slogan, "Expanding the druggable proteome to drug intrinsically disordered proteins," encapsulates its mission to discover and develop small molecule cancer drugs. These medications are designe...
We will tell you when either one moves
BounceWatch watches AI Proteins and Ambagon Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at AI Proteins and Ambagon Therapeutics — by email.
Frequently Asked Questions
Compare AI Proteins with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at AI Proteins on 15 Jun 2026, and Ambagon Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
